Evolus (EOLS) Other Non-Current Liabilities (2018 - 2021)
Evolus (EOLS) reported Other Non-Current Liabilities of $44.7 million for Q4 2021, up 7.69% on a YoY basis from $41.5 million in Q4 2020, and up 7.69% quarter-over-quarter from $41.5 million in Q4 2020.
Evolus (EOLS) Other Non-Current Liabilities (2018 - 2021) Analysis & Trends
Evolus has reported Other Non-Current Liabilities for 4 years, with the latest figure at $44.7 million in Q4 2021.
- For the quarter ending Q4 2021, Other Non-Current Liabilities rose 7.69% year-over-year to $44.7 million; the trailing twelve-month figure through Dec 2021 stood at $44.7 million (up 7.69% YoY), and the FY2021 full-year result was $44.7 million, up 7.69% from the prior year.
- Other Non-Current Liabilities for Q4 2021 stood at $44.7 million, up from $41.5 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $51.1 million in Q3 2018, with the low at $34.2 million in Q1 2020.
- Historically, Other Non-Current Liabilities has averaged $44.9 million across 4 years, with a median of $45.3 million in 2019.
- Annual changes were most pronounced in 2019 — Other Non-Current Liabilities increased 13.05% — and 2020, when it retreated 25.46%.
- Evolus' Other Non-Current Liabilities stood at $50.2 million in 2018, then declined by 10.99% to $44.7 million in 2019, then fell by 7.02% to $41.5 million in 2020, then advanced by 7.69% to $44.7 million in 2021.
- The last three Other Non-Current Liabilities figures came in at $44.7 million (Q4 2021), $41.5 million (Q4 2020), and $34.2 million (Q1 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 44.74 Mn |
| Dec 31, 2020 | 41.55 Mn |
| Mar 31, 2020 | 34.22 Mn |
| Dec 31, 2019 | 44.68 Mn |
| Jun 30, 2019 | 47.17 Mn |
| Mar 31, 2019 | 45.90 Mn |
| Dec 31, 2018 | 50.20 Mn |
| Sep 30, 2018 | 51.10 Mn |
| Jun 30, 2018 | 48.80 Mn |
| Mar 31, 2018 | 40.60 Mn |